BVF as of Sept. 30, 2019
Portfolio Holdings for BVF
BVF holds 59 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Merus N V (MRUS) | 8.7 | $83M | 4.6M | 17.82 | |
| Springworks Therapeutics (SWTX) | 6.5 | $62M | 2.8M | 21.68 | |
| Ionis Pharmaceuticals (IONS) | 5.9 | $56M | 936k | 59.91 | |
| Ac Immune Sa (ACIU) | 5.9 | $56M | 11M | 4.95 | |
| Cytokinetics (CYTK) | 5.0 | $47M | 4.2M | 11.38 | |
| Galapagos Nv- (GLPG) | 4.9 | $47M | 305k | 152.66 | |
| Xoma Corp Del (XOMA) | 3.7 | $35M | 1.8M | 19.52 | |
| Arcus Biosciences Incorporated (RCUS) | 3.4 | $33M | 3.6M | 9.10 | |
| Blueprint Medicines (BPMC) | 3.4 | $32M | 438k | 73.47 | |
| Glycomimetics | 3.3 | $32M | 7.4M | 4.31 | |
| Kura Oncology (KURA) | 3.2 | $30M | 2.0M | 15.17 | |
| Replimune Group (REPL) | 2.6 | $24M | 1.7M | 13.90 | |
| Mirati Therapeutics | 2.5 | $24M | 309k | 77.91 | |
| Deciphera Pharmaceuticals | 2.5 | $24M | 711k | 33.94 | |
| Molecular Templates | 2.3 | $22M | 3.4M | 6.59 | |
| Calithera Biosciences | 2.2 | $21M | 6.8M | 3.09 | |
| Pieris Pharmaceuticals | 1.9 | $18M | 5.3M | 3.41 | |
| Infinity Pharmaceuticals (INFIQ) | 1.9 | $18M | 17M | 1.03 | |
| Dicerna Pharmaceuticals | 1.9 | $18M | 1.2M | 14.36 | |
| Xenon Pharmaceuticals (XENE) | 1.6 | $16M | 1.7M | 9.01 | |
| ArQule | 1.6 | $15M | 2.1M | 7.17 | |
| Five Prime Therapeutics | 1.5 | $15M | 3.8M | 3.87 | |
| Cytomx Therapeutics (CTMX) | 1.5 | $14M | 1.9M | 7.38 | |
| Syndax Pharmaceuticals (SNDX) | 1.4 | $13M | 1.8M | 7.47 | |
| Ideaya Biosciences (IDYA) | 1.4 | $13M | 1.4M | 9.00 | |
| Anaptysbio Inc Common (ANAB) | 1.3 | $12M | 354k | 34.99 | |
| Akero Therapeutics (AKRO) | 1.1 | $11M | 472k | 22.75 | |
| Spero Therapeutics (SPRO) | 1.1 | $10M | 940k | 10.60 | |
| Chemocentryx | 1.0 | $9.6M | 1.4M | 6.78 | |
| Corvus Pharmaceuticals (CRVS) | 1.0 | $9.2M | 3.0M | 3.01 | |
| Essa Pharma (EPIX) | 0.9 | $8.9M | 2.6M | 3.37 | |
| Galmed Pharmaceuticals | 0.9 | $8.8M | 1.8M | 4.78 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $8.2M | 683k | 12.01 | |
| Prevail Therapeutics Ord | 0.8 | $8.1M | 657k | 12.28 | |
| Verastem | 0.8 | $7.7M | 6.3M | 1.21 | |
| Ovid Therapeutics (OVID) | 0.8 | $7.5M | 2.3M | 3.24 | |
| X4 Pharmaceuticals | 0.8 | $7.5M | 594k | 12.71 | |
| Forward Pharma A/s | 0.7 | $6.6M | 6.5M | 1.02 | |
| Mersana Therapeutics | 0.7 | $6.4M | 4.0M | 1.58 | |
| Genocea Biosciences (GNCAQ) | 0.6 | $6.1M | 2.1M | 2.90 | |
| Cti Biopharma | 0.6 | $5.8M | 6.9M | 0.83 | |
| Eiger Biopharmaceuticals | 0.6 | $5.5M | 540k | 10.25 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.6 | $5.3M | 2.7M | 1.99 | |
| Spring Bk Pharmaceuticals In | 0.5 | $4.8M | 1.4M | 3.50 | |
| Biolinerx | 0.5 | $4.6M | 1.7M | 2.64 | |
| Sunesis Pharmaceuticals Inc Ne | 0.5 | $4.5M | 6.2M | 0.72 | |
| Alpine Immune Sciences | 0.5 | $4.5M | 1.1M | 3.92 | |
| Gamida Cell | 0.5 | $4.3M | 1.0M | 4.33 | |
| Mei Pharma | 0.4 | $3.7M | 2.2M | 1.68 | |
| Sutro Biopharma (STRO) | 0.3 | $3.1M | 344k | 9.09 | |
| Erytech Pharma Sa | 0.3 | $2.8M | 625k | 4.44 | |
| Surface Oncology | 0.2 | $1.5M | 1.1M | 1.42 | |
| Mereo Biopharma Group Plc ads (MREO) | 0.2 | $1.5M | 523k | 2.90 | |
| Regulus Therapeutics | 0.1 | $1.5M | 2.0M | 0.72 | |
| Aduro Biotech | 0.1 | $1.1M | 1.0M | 1.06 | |
| Brickell Biotech | 0.1 | $947k | 228k | 4.15 | |
| Contrafect | 0.1 | $684k | 1.9M | 0.36 | |
| Albireo Pharma | 0.1 | $580k | 29k | 20.00 | |
| Novus Therapeutics | 0.1 | $522k | 829k | 0.63 |
